Modified E. coli heat labile enterotoxin LTR192G

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

Escherichia Coli Infection

Phase 1

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

CompletedNCT01382095

U.S. Army Medical Research and Development CommandEscherichia Coli Infection

Start: 2011-07-31End: 2013-04-30Updated: 2015-04-27

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

CompletedNCT01644565

U.S. Army Medical Research and Development CommandEscherichia Coli Infection

Start: 2012-08-31End: 2015-06-30Updated: 2021-02-12